Results 111 to 120 of about 34,611,146 (146)

Angiotensin 1-7 and the Non-Peptide MAS-R Agonist AVE0991 Inhibit Breast Cancer Cell Migration and Invasion. [PDF]

Biomedicines
Alfoudiry MM, Khajah MA.
europepmc   +1 more source

Losartan is more effective than angiotensin (1-7) in preventing thyroxine-induced renal injury in the rat. [PDF]

Thyroid Res
Malatiali S, Oriowo M.
europepmc   +1 more source

Angiotensin (1-7) Improves Pancreatic Islet Function via Upregulating PDX-1 and GCK: A Dose-Dependent Study in Mice. [PDF]

Int J Endocrinol
Lin Z, Lin J, Huang A, Zhang Z, Wu X, Yin G, Wei C, Xu W.   +7 more
europepmc   +1 more source

Administration of Topical NorLeu³Angiotensin(1-7) Minimizes Fibrotic Corneal Healing in Stellate Wound: A 28-Day Study. [PDF]

Int J Mol Sci
Chester C, Moreno-Diaz EA, Hu W, Chen B, Alshammari M, Humayun MS, Camarillo JCM, Louie SG.   +7 more
europepmc   +1 more source

Editorial Note: Olmesartan Potentiates the Anti-Angiogenic Effect of Sorafenib in Mice Bearing Ehrlich's Ascites Carcinoma: Role of Angiotensin (1-7). [PDF]

PLoS One
PLOS ONE Editors.
europepmc   +1 more source

Angiotensin 1-7 and a telomerase reverse transcriptase activator individually restore vasodilatory capacity within the human microcirculation previous SARS-CoV-2 infection. [PDF]

Cardiovasc Res
Nishijima Y, Hader SN, Birch EC, Chen Y, Widlansky ME, Beyer AM.   +5 more
europepmc   +1 more source

Interaction of SARS-CoV-2 and SARS-CoV-2 vaccines with renin angiotensin aldosterone system, clinical outcomes, and angiotensin (1-7) as a physiological treatment recommendation: hypothesis and theory article. [PDF]

Front Med (Lausanne)
Aktaş AR.
europepmc   +1 more source

Activation of central Angiotensin-(1-7)/Mas receptor alleviates synaptic damage in diabetes-associated cognitive impairment via modulating AKT/FOXO1/PACAP axis. [PDF]

Int J Biol Sci
Tian S, Wu T, Zhang Z, Lv S, Ji X, Zhao Z, Ma X, Wang J, Bi Y.   +8 more
europepmc   +1 more source

Angiotensin-(1-7) infusion in COVID-19 patients admitted to the ICU: a seamless phase 1-2 randomized clinical trial. [PDF]

Ann Intensive Care
Martins ALV, Annoni F, da Silva FA, Bolais-Ramos L, de Oliveira GC, Ribeiro RC, Diniz MML, Silva TGF, Pinheiro BD, Rodrigues NA, Dos Santos Matos AH, Motta-Santos D, Campagnole-Santos MJ, Verano-Braga T, Taccone FS, Santos RAS.   +15 more
europepmc   +1 more source